ATE233317T1 - Dna verbindungen mit mannuronan c-5-epimerase kodierenden sequenzen - Google Patents

Dna verbindungen mit mannuronan c-5-epimerase kodierenden sequenzen

Info

Publication number
ATE233317T1
ATE233317T1 AT93923068T AT93923068T ATE233317T1 AT E233317 T1 ATE233317 T1 AT E233317T1 AT 93923068 T AT93923068 T AT 93923068T AT 93923068 T AT93923068 T AT 93923068T AT E233317 T1 ATE233317 T1 AT E233317T1
Authority
AT
Austria
Prior art keywords
pct
epimerase
sequences encoding
enzymes
date
Prior art date
Application number
AT93923068T
Other languages
English (en)
Inventor
Helga Ertesvag
Svein Valla
Gudmund Skjak-Brak
Bjorn Larsen
Original Assignee
Fmc Biopolymer As
Nobipol
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fmc Biopolymer As, Nobipol filed Critical Fmc Biopolymer As
Application granted granted Critical
Publication of ATE233317T1 publication Critical patent/ATE233317T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90Isomerases (5.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/24Preparation of compounds containing saccharide radicals produced by the action of an isomerase, e.g. fructose
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/831Azotobacter

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
AT93923068T 1992-10-08 1993-10-08 Dna verbindungen mit mannuronan c-5-epimerase kodierenden sequenzen ATE233317T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929221163A GB9221163D0 (en) 1992-10-08 1992-10-08 Dna compounds
PCT/NO1993/000151 WO1994009124A1 (en) 1992-10-08 1993-10-08 Dna compounds comprising sequences encoding mannuronan c-5-epimerase

Publications (1)

Publication Number Publication Date
ATE233317T1 true ATE233317T1 (de) 2003-03-15

Family

ID=10723148

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93923068T ATE233317T1 (de) 1992-10-08 1993-10-08 Dna verbindungen mit mannuronan c-5-epimerase kodierenden sequenzen

Country Status (15)

Country Link
US (1) US5939289A (de)
EP (1) EP0665882B1 (de)
JP (1) JP3665905B2 (de)
KR (1) KR100338997B1 (de)
AT (1) ATE233317T1 (de)
AU (1) AU677796B2 (de)
CA (1) CA2146658C (de)
DE (1) DE69332714T2 (de)
DK (1) DK0665882T3 (de)
ES (1) ES2193144T3 (de)
FI (1) FI120543B (de)
GB (1) GB9221163D0 (de)
NO (1) NO319242B1 (de)
NZ (1) NZ256912A (de)
WO (1) WO1994009124A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9701454D0 (sv) 1997-04-18 1997-04-18 Ulf Lindahl new DNA sequences and a process for enzyme manufacture
EP1171597A2 (de) * 1999-04-12 2002-01-16 Agensys, Inc. In prostatakarzinom exprimiertes prostata-begrenztes gen 30p3c8
EP1181375A2 (de) * 1999-05-10 2002-02-27 CP Kelco APS Sulfohydrolase, korrespondierende aminosäuresequenzen und nukleinsäuresequenzen, und davon abgeleitete zusammensetzungen, verfahren und produkte
NZ522623A (en) * 2000-05-26 2003-10-31 Arla Foods Amba A beta galactosidase with transglactosylase activity isolated from a bifidobacterium
AU1717402A (en) * 2000-12-08 2002-06-18 Biotie Therapies Corp Glucuronyl c5-epimerase, dna encoding the same and uses thereof
NO326145B1 (no) 2001-11-30 2008-10-06 Fmc Biopolymer As Fremgangsmate for a stimulere vektokning hos pattedyr, fugler og krypdyr.
NO320671B1 (no) * 2001-11-30 2006-01-16 Fmc Biopolymer As Fremgangsmate for a stimulere vektokning i fisk.
NO20023581D0 (no) * 2002-07-26 2002-07-26 Fmc Biopolymer As Nye mutantstammer av Pseudomonas fluorescens og varianter derav, metoder for produksjon og bruk derav til produksjon avalginat
FR2849056B1 (fr) * 2002-12-19 2007-07-13 Centre Nat Rech Scient Mannuronane c5-epimerases d'algues brunes, procedes d'obtention et utilisations
DE10349082A1 (de) 2003-10-22 2005-05-25 Wacker-Chemie Gmbh Wässrige Polymerdispersionen
DK2268142T3 (en) 2007-11-27 2017-05-22 Algipharma As USING ALGINATED OLIGOMERS TO FIGHT BIOFILM
WO2009134368A2 (en) * 2008-04-29 2009-11-05 Marshall University Research Corporation Methods of producing bacterial alginates
SI2437783T1 (sl) 2009-06-03 2014-04-30 Algipharma As Obdelava bakterije acinetobacter z alginatnimi oligomeri in antibiotiki
GB0909529D0 (en) 2009-06-03 2009-07-15 Algipharma Ipr As Alginate oligomers for the inhibition of microbial adherence to surfaces
GB0909557D0 (en) 2009-06-03 2009-07-15 Algipharma Ipr As Anti-microbial alginate oligomers
DE102010062839A1 (de) 2010-12-10 2012-06-14 Wacker Chemie Ag Wässrige, vernetzbare Dispersionen auf der Basis von Organosiliciumverbindungen
GB201116010D0 (en) 2011-09-15 2011-10-26 Algipharma As Use of alginate oligomers to enhance the effects of antifungal agents
GB201305128D0 (en) * 2013-03-20 2013-05-01 Norwegian Univ Sci & Tech Ntnu Epimerases and methods for their identification
GB201322777D0 (en) 2013-12-20 2014-02-05 Algipharma As Use of alginate oligomers as blood anticoagulants
GB201504878D0 (en) 2015-03-23 2015-05-06 Algipharma As Use of alginate oligomers and CFTR modulators in the treatment of conditions associated with CFTR dysfuntion
GB201517639D0 (en) 2015-10-06 2015-11-18 Algipharma As Use of alginate oligomers to treat or prevent microbial overgrowth in the intestinal tract
GB201908639D0 (en) 2019-06-17 2019-07-31 Algipharma Ipr As Use of alginate oligomers in the anticoagulation therapy of subjects at risk of blood clots which have an abnormally dense microstructure
CN121001710A (zh) 2022-12-30 2025-11-21 阿尔吉法玛公司 提高口服多肽治疗剂的全身生物利用度的组合物和方法
WO2026008878A1 (en) 2024-07-04 2026-01-08 Algipharma As Antimycotic polyene-alginate oligomer conjugates

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO845059L (no) * 1984-12-17 1986-06-18 Sintef Inst For Marin Biokjemi Fremgangsmaate for fremstilling av alginater med endrede fysikalske egenskaper samt anvendelse av disse alginater.

Also Published As

Publication number Publication date
ES2193144T3 (es) 2003-11-01
EP0665882B1 (de) 2003-02-26
DK0665882T3 (da) 2003-03-31
WO1994009124A1 (en) 1994-04-28
NO951364D0 (no) 1995-04-06
FI120543B (fi) 2009-11-30
FI951680A0 (fi) 1995-04-07
NO951364L (no) 1995-04-06
AU5287393A (en) 1994-05-09
NO319242B1 (no) 2005-07-04
KR950703642A (ko) 1995-09-20
FI951680L (fi) 1995-04-07
GB9221163D0 (en) 1992-11-25
KR100338997B1 (ko) 2002-11-11
DE69332714D1 (de) 2003-04-03
JP3665905B2 (ja) 2005-06-29
CA2146658A1 (en) 1994-04-28
US5939289A (en) 1999-08-17
EP0665882A1 (de) 1995-08-09
CA2146658C (en) 2006-03-14
NZ256912A (en) 1997-09-22
DE69332714T2 (de) 2003-12-11
AU677796B2 (en) 1997-05-08
JPH08504572A (ja) 1996-05-21

Similar Documents

Publication Publication Date Title
ATE233317T1 (de) Dna verbindungen mit mannuronan c-5-epimerase kodierenden sequenzen
DE69535543D1 (de) Für enzyme, die die fähigkeit besitzen lineare alpha 1,4-glucane in pflanzen, pilzen und mikroorganismen zu synthesieren, kodierende dna sequenzen
EP0723555A4 (de) Chimäre proteine zur vermeidung der komplementaktivierung
BG101384A (en) New pesticide proteins and strains
ZA939621B (en) Protein named component B
IL106646A0 (en) Dna sequences which lead to the formation of polyfructans(levans),plasmids containing these dna sequences and the use of these plasmids for preparing transgenic plants
ATE201236T1 (de) Zur ortsspezifischen rekomination fähige agrobakterium stämme
IT1272179B (it) Metodologia per riprodurre in vitro l'attivita' proteolitica della proteasi ns3 del virus hcv.
AU641568B2 (en) Polypeptide,DNA fragment encoding the same and process for producing the same, and enzyme inhibition process, drug composition and methods of treating using the same
GB9209993D0 (en) Vaccines
DK0677116T3 (da) Fremgangsmåde til fremstilling af immunosuppressive midler og en ny mikroorganismeart til anvendelse deri
IE812919L (en) Mature thaumatin
DK0656940T3 (da) Gensekvenser, som koder for glykosyltransferase-enzymer, og anvendelser deraf
YU14602A (sh) Signalna sekvenca za proizvodnju leu-hirudina pomoću sekrecija e.coli u medijumu kulture
WO1992013078A3 (en) Pasteurella haemolytica glycoprotease gene and the purified enzyme
ATE314477T1 (de) An der streptogramin biosynthese beteiligte polypeptide, ihre kodierenden nukleotidsequenzen und ihre verwendung
DE69427857D1 (de) Markiergen
ATE175237T1 (de) Polypeptide beteiligt an der kobalamin- und/oder kobamid-biosynthese, für diese kodierende dns- sequencen, und ihre herstellung und vewendung.
KR950700988A (ko) 미생물, 이들의 제조방법 및 이들의 사용(Micro-organisms, preparation method therefor and uses thereof)
CA2068994A1 (en) Synchronous selective signalling system
ATE202798T1 (de) D-aminosäure-oxidase kodierendes dns-fragment
ZA949807B (en) Regulatory nucleic acid sequences and uses
MD232C2 (ro) Mediu pentru cultivarea microorganismelor Campylobacter jejuni/coli
AU5779690A (en) Mutation of the rhinovirus system
DE59611353D1 (de) Transketolase-verwandtes protein

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties